Greenwood Capital Associates’s Aspen Aerogels ASPN Stock Holding History
Bought
Maintained
Sold
Other funds holding ASPN
KL
OCMI
GKFF
NIM
AIC
TAM
Greenwood Capital Associates's ASPN Position: Q1 2025 in Review
Greenwood Capital Associates sold out of Aspen Aerogels (ASPN) in Q1 2025, closing a stake of 36,938 shares — an estimated $439K sold.
Greenwood Capital Associates first reported a position in ASPN in Q2 2020 and held it in 19 quarters. The position peaked at $3.62M in Q4 2021. 221 funds tracked by Wall St. Rank hold ASPN as of Q1 2025.
- Greenwood Capital Associates reported no remaining Aspen Aerogels position as of Q1 2025 after selling out during the quarter.
- Greenwood Capital Associates sold 36,938 Aspen Aerogels shares in Q1 2025, an estimated $439K.
- Greenwood Capital Associates first reported a position in Aspen Aerogels in Q2 2020 and held it in 19 quarters.
- Greenwood Capital Associates's Aspen Aerogels position peaked at $3.62M in Q4 2021.
- 221 funds tracked by Wall St. Rank held Aspen Aerogels as of Q1 2025.
Based on Greenwood Capital Associates's 13F filing for Q1 2025, filed 15 Apr 2025.